Exploring the role of mu opioid receptors in the therapeutic potential and abuse liability of (S)-ketamine.
作者信息
Levinstein Marjorie R, Michaelides Michael
机构信息
Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 21224, USA.
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
出版信息
Neuropsychopharmacology. 2024 Jan;49(1):315-316. doi: 10.1038/s41386-023-01652-x.
Abstract
摘要
相似文献
1
Exploring the role of mu opioid receptors in the therapeutic potential and abuse liability of (S)-ketamine.探索μ阿片受体在（S）-氯胺酮治疗潜力和滥用倾向中的作用。
Neuropsychopharmacology. 2024 Jan;49(1):315-316. doi: 10.1038/s41386-023-01652-x.
2
Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain.在急性疼痛小鼠模型中，右美沙芬和氯胺酮增强了μ阿片受体激动剂而非δ或κ阿片受体激动剂的镇痛作用。
Pharmacol Biochem Behav. 2002 Dec;74(1):73-86. doi: 10.1016/s0091-3057(02)00961-9.
3
Additive and subadditive antiallodynic interactions between μ-opioid agonists and N-methyl D-aspartate antagonists in male rhesus monkeys.雄性恒河猴中μ-阿片受体激动剂与N-甲基-D-天冬氨酸拮抗剂之间的相加和亚相加抗痛觉过敏相互作用。
Behav Pharmacol. 2018 Feb;29(1):41-52. doi: 10.1097/FBP.0000000000000336.
4
The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liability.阿片受体三联激动剂DPI-125产生的镇痛作用具有较少的呼吸抑制且滥用可能性降低。
Acta Pharmacol Sin. 2017 Jul;38(7):977-989. doi: 10.1038/aps.2017.14. Epub 2017 May 15.
5
Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability.μ 阿片受体激活介导（S）-氯胺酮在大鼠中的强化作用：对滥用倾向的影响。
Biol Psychiatry. 2023 Jun 15;93(12):1118-1126. doi: 10.1016/j.biopsych.2022.12.019. Epub 2022 Dec 24.
6
Peripheral antinociception induced by ketamine is mediated by the endogenous opioid system.氯胺酮诱导的外周抗伤害作用是由内源性阿片系统介导的。
Eur J Pharmacol. 2019 Dec 15;865:172808. doi: 10.1016/j.ejphar.2019.172808. Epub 2019 Nov 15.
7
Selective enhancement of fentanyl-induced antinociception by the delta agonist SNC162 but not by ketamine in rhesus monkeys: Further evidence supportive of delta agonists as candidate adjuncts to mu opioid analgesics.Delta 激动剂 SNC162 而非氯胺酮增强芬太尼诱发的抗伤害作用：进一步支持 delta 激动剂作为 μ 阿片类镇痛药辅助药物的候选物。
Pharmacol Biochem Behav. 2010 Dec;97(2):205-12. doi: 10.1016/j.pbb.2010.07.019. Epub 2010 Aug 3.
8
Exploring μ-Opioid Receptor Splice Variants as a Specific Molecular Target for New Analgesics.探索μ-阿片受体剪接变异体作为新型镇痛药的特定分子靶标。
Curr Top Med Chem. 2020;20(31):2866-2877. doi: 10.2174/1568026620666200922113430.
9
Abuse Potential of Biased Mu Opioid Receptor Agonists.偏向性 μ 阿片受体激动剂的滥用潜力。
Trends Pharmacol Sci. 2018 Nov;39(11):916-919. doi: 10.1016/j.tips.2018.08.007.
10
Contribution of the opioid system to depression and to the therapeutic effects of classical antidepressants and ketamine.阿片系统对抑郁症的贡献以及经典抗抑郁药和氯胺酮的治疗效果。
Life Sci. 2023 Aug 1;326:121803. doi: 10.1016/j.lfs.2023.121803. Epub 2023 May 26.
引用本文的文献
1
Ketamine and Major Ketamine Metabolites Function as Allosteric Modulators of Opioid Receptors.氯胺酮及其主要代谢产物作为阿片受体的变构调节剂。
Mol Pharmacol. 2024 Oct 17;106(5):240-252. doi: 10.1124/molpharm.124.000947.
2
Esketamine in depression: putative biomarkers from clinical research.艾氯胺酮治疗抑郁症：临床研究中的潜在生物标志物
Eur Arch Psychiatry Clin Neurosci. 2024 Jul 13. doi: 10.1007/s00406-024-01865-1.
本文引用的文献
1
Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability.μ 阿片受体激活介导（S）-氯胺酮在大鼠中的强化作用：对滥用倾向的影响。
Biol Psychiatry. 2023 Jun 15;93(12):1118-1126. doi: 10.1016/j.biopsych.2022.12.019. Epub 2022 Dec 24.
2
6-O-(2-[F]Fluoroethyl)-6-O-Desmethyl-Diprenorphine ([F]FE-DPN) Preferentially Binds to Mu Opioid Receptors In Vivo.6-O-(2-[F]氟乙基)-6-O-去甲基二丙诺啡([F]FE-DPN)在体内优先与μ阿片受体结合。
Mol Imaging Biol. 2023 Apr;25(2):384-390. doi: 10.1007/s11307-022-01767-5. Epub 2022 Aug 23.
3
Synergistic Effect of Ketamine and Buprenorphine Observed in the Treatment of Buprenorphine Precipitated Opioid Withdrawal in a Patient With Fentanyl Use.氯胺酮和丁丙诺啡在治疗芬太尼使用者丁丙诺啡诱发阿片戒断中的协同作用
J Addict Med. 2022;16(4):483-487. doi: 10.1097/ADM.0000000000000929. Epub 2021 Nov 16.
4
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability.氯胺酮对映异构体的药理学和行为学差异：对滥用倾向的影响。
Mol Psychiatry. 2021 Nov;26(11):6704-6722. doi: 10.1038/s41380-021-01093-2. Epub 2021 Apr 15.
5
Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.氯胺酮与中国仓鼠卵巢细胞中表达的重组μ、κ和δ阿片受体的立体选择性相互作用。
Anesthesiology. 1999 Jan;90(1):174-82. doi: 10.1097/00000542-199901000-00023.
Zotero 插件